Clinical Trial: Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients With Inoperable
Original Primary Outcome:
- Change from Baseline to Week 16 in 6-Minute Walk Test distance
- Change from Baseline to Week 16 in Pulmonary Vascular Resistance at rest
Current Secondary Outcome:
- Change from Baseline to Week 16 in modified NYHA functional class [ Time Frame: Week 16 ]
- Time to clinical worsening [ Time Frame: Time to clinical worsening ]
Original Secondary Outcome:
- Change from Baseline to Week 16 in modified NYHA functional class
- Time to clinical worsening
Information By: Actelion
Dates:
Date Received: April 10, 2006
Date Started: October 2005
Date Completion:
Last Updated: February 11, 2010
Last Verified: February 2010